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Abstract
Background: The main objective of the current study was to develop and validate a French exercise stereotype
scale for people living with HIV (PLHIV) in order to gain visibility to the possible barriers and facilitators for exercise
in PLHIV and thus enhance their quality of life.
Methods: A series of four complementary studies was carried out with a total sample of 524 participants to:
(a) develop a preliminary version of the HIV Exercise Stereotype Scale (HIVESS) (Stage 1), (b) confirm the factorial
structure of the instrument (Stage 2), (c) evaluate the stability of the instrument (Stage 3), and (d) examine the
construct and divergent validity of the scale (Stage 4).
Results: Results provided support for a 14-item scale with three sub-scales reporting stereotypes related to exercise
benefits, exercise risks and lack of capacity for exercise with Cronbach’s alphas of .77, .69 and .76 respectively. Results
showed good factorial structure, strong reliability and indicators of convergent validity relating to self-efficacy, exercise
and quality of life.
Conclusion: The HIVESS presented satisfactory psychometric properties, constitutes a reliable and valid instrument to
measure exercise stereotypes among PLHIV and has applications for future research and clinical practice.
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Background
The positive effects of exercise for people living with HIV
(PLHIV) are now thoroughly reported in scientific litera-
ture. A recent meta-analysis [1], indicated that moderate
exercise presents beneficial physical and psychological
effects for this population (e.g., improvement of fitness,
body composition and quality of life). Further physical
effects noted are the moderation of the side effects of anti-
retroviral therapy (e.g., reducing and/or preventing uneven
distribution of body fat) [2], and of cardiopulmonary
fitness [3]. These physical effects coexist with notable psy-
chological benefits such as reduced depression [4, 5] or
improved self-perceptions and self-esteem [6]. Greater
quality of social relationships [7] and life satisfaction has
also been reported comparably to non-exercising PLHIV
[8]. Lastly, some studies evidenced the ability of exercise
to better antiretroviral therapy adherence [9] and to hin-
der anti-inflammatory consequences [10].
Regardless of the extensive literature related to the
benefits of exercise in PLHIV, a large proportion of this
population is not sufficiently active according to current
recommendations [11, 12], for adults between 18 and
64 years of age, requiring at least, 150 min of moderate ex-
ercise and two sessions of muscle strengthening workout
per week [13]. These findings are of concern and encour-
age further identifying barriers to exercise participation.
Research related to exercise barriers in PLHIV is sparse.
* Correspondence: lgray@unice.fr
1Université Côte D’azur, LAMHESS, Nice, France
Full list of author information is available at the end of the article
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Gray et al. Health and Quality of Life Outcomes  (2016) 14:157 
DOI 10.1186/s12955-016-0562-z
In a study conducted in Rwandan PLHIV receiving high
active antiretroviral therapy [14], the main perceived
barriers were lack of motivation (30.5 %), lack of time
(25.3 %) and fear of worsening the disease (24.3 %).
Through a qualitative study conducted on South African
PLHIV, a wide range of obstacles to participation, related
to both the psychological sphere (e.g., low-energy levels,
psychological complaints and stress levels) and the envir-
onmental and social spheres (e.g., physical environment,
social environment, domestic abuse and crime) were
isolated [15]. More recently, it has been reported that
prominent exercise barriers include HIV symptoms
(i.e., neuropathy, lipoatrophy), antiretroviral therapy ef-
fects (lipodystrophy) and fatigue, but also decreased
motivation, depression, negative self-perceptions, and
apprehension concerning the risks of exercise such as
sustaining an injury [15].
These last results suggest that insufficiently physically
active PLHIV might have negative beliefs about exercise
effects (e.g., perceived risks), which might limit their
participation in exercise. Furthermore, these negative
beliefs might reflect the internalization of stereotypes
related to physical weakness and decline due to HIV
disease. Stereotypes refer to shared beliefs concerning
personal characteristics, generally personality traits,
and the behaviors of a group of persons [16]. According
to the stereotype embodiment theory [17], stereotypes
are embodied when their assimilation from the surround-
ing culture leads to self-definitions that, in turn, influence
functioning and health. In the case of HIV, internalized
stigma has shown a relation to lower mental health and
social support, and greater HIV symptoms [18].
An emerging body of literature has focused on the spe-
cific influence of exercise stereotypes on different popula-
tions such as the elderly or individuals with chronic
diseases. Particular measures have been generated to
investigate exercise stereotypes in these populations. For
example, the “Aging Stereotypes and Exercise Scale” was
developed and validated to assess different aspects of
aging stereotypes in the exercise sphere such as (a) stereo-
types regarding exercise benefits, (b) stereotypes about
exercise risks, and (c) stereotypes related to self-efficacy
[19]. This line of research indicates that endorsement of
negative aging exercise stereotypes is related to lower levels
of exercise among the elderly [20, 21]. Another stereotypes-
type scale is the “Cancer Exercise Stereotypes Scale” (CESS)
[22], which evaluates stereotypes related to exercise in can-
cer patients: (a) stereotypes related to the lack of interest in
exercise; (b) stereotypes regarding exercise self-efficacy; (c)
stereotypes about the side effects of treatment; (d) stereo-
types related to the risks of exercise and; (e) stereotypes as-
sociated with the benefits of exercise. In both scales, some
subscales refer to negative exercise stereotypes and others
refer to positive exercise stereotypes.
HIV/AIDS-related stigma is continuously brought to
mind, in any discussion about effective responses to the
epidemic, as a problem of detrimental and tenacious
nature [23], several internalized AIDS-stigma scales have
hereby been developed [24, 25]. However, no valid tool
is currently available to measure stereotypes related to
exercise in PLHIV. Taking into consideration the theor-
etical and conceptual link between exercise stereotypes
and behaviors, there is a need to measure stereotypes
that act as barriers or facilitators to exercise in PLHIV.
This study’s main objective was thus to develop and val-
idate the HIV Exercise Stereotypes Scale (HIVESS). The
HIVESS could be used (1) in research to better explain
the psychosocial factors related to exercise in PLHIV,
and (2) in practice to enable health and exercise profes-
sionals to conceive effective intervention strategies that
take into account exercise barriers and how to modify
them favorably.
Methods
The HIVESS was developed and validated following
Vallerand’s procedure [26], including: (i) developing an
initial version and assessing the clarity of the items, (ii)
analyzing and confirming the factorial structure of the
instrument, (iii) analyzing the stability of the tool over
time, and (iv) evidencing proof of construct validity by
testing the convergent validity and discriminant validity
of the scale.
To perform the successive stages in developing and val-
idating the scale, a total of 420 voluntary French-speaking
PLHIV (Mage = 52.51; SD = 11.44), 154 voluntary French-
speaking healthy individuals (Mage = 28.04; SD = 10.45),
including 50 French-speaking faculty students (Mage =
23.08; SD = 2.25) were recruited Participants were in-
formed of the study during routine consultations or vari-
ous announcements on social media and in a local
newspaper. PLHIV were recruited from three French hos-
pitals by hospital staff and researchers following certain
inclusion criteria (i.e., at least 10 years of therapy; no co-
infection or other diseases). Healthy individuals and
students were recruited in the local area by researchers.
Ethical approval as well as participants’ informed written
consent was obtained for these studies.
Stage 1: exploratory version and content clarity
In the first stage of this study the aim was to compile an
initial version of the HIVESS. Three researchers special-
ized in the field of health psychology and four PLHIV
formed an ad hoc committee and stipulated a series of
items based on (i) content analyses of previous semi-
structured interviews focused on exercise beliefs in
PLHIV and (ii) two validated scales measuring different
dimensions of exercise stereotypes in older adults and
cancer patients [19, 22]. Items were thus theoretically
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prompted and formulated using conventional recom-
mendations for understanding and wording literacy
[27]. The concepts of qualitative saturation decided the
number of initial items. Saturation was deemed attained
when no new relevant item emerged [28]. During this
process and in anticipation of items being deleted dur-
ing the refinement process, items were added to each
stereotype category [29]. The Delphi method was then
used to select items [30]. The list of items was pre-
sented repeatedly until at least 80 % of the raters came
to a consensus [31]. A first panel of PLHIV was asked
to complete an assessment of the investigative version
of the instrument after an initial expert panel review.
Participants were invited to assess the clarity of each
item on a six-point Likert scale ranging from 1 = “not
at all clear” to 6 = “completely clear”. Each participant
was interviewed as this qualitative procedure allowed
discussing each item as to its pertinence, endorsement
and highlighting possible needs for alterations. As sug-
gested by Morey (2003) [29] participants were explicitly
encouraged to provide feedback on items rated as being
low in quality. The evaluated items, to which mean
scores of “4 and/or less” were attributed, were considered
as ambiguous or misunderstood. These items where then
modified or reformulated according to participant com-
ments and suggestions made by the researchers [26]. A
second panel of PLHIV in a method comparable to the
first evaluation protocol then assessed the revised version
of the instrument.
Stage 2: factorial structure analysis
This stage aimed at examining the factorial structure of
the HIVESS. As item generation was theory driven and
based on existing exercise stereotypes scales (e.g., ASES
[19]; CESS [22]), the number of factors was predefined.
Therefore, maximum likelihood estimation confirmatory
factorial analysis (CFA) was conducted in AMOS v7.0 to
test the validity of the factor model [32]. Factor analysis
is considered possible with a minimal sample of ques-
tionnaire items amounting to five times the number of
items [33]. Each item was identified as an indicator of a
single underlying stereotype sub-scale, and no items
were specified to cross-load. The following indicators:
chi square (χ2; significant values p ≤ .05), the Compara-
tive Fit Index (CFI; values above 0.90), the Tucker-Lewis
Index (TLI; values above 0.90), the Root Mean Square
Error of Approximation (RMSEA; values below 0.08),
and the 90 % Confidence Interval of the RMSEA
(RMSEA 90 % CI; values ranging from 0 to 0.08) were
used to assess competence of the model fit [34–36].
Sources of poor fit were examined through modification
indices [37]. Cronbach’s alphas [38] were also deter-
mined to test the internal consistency of each subscale,
with convention recommending values greater than 0.70.
Stage 3: temporal stability
Temporal stability, or “test-retest”, is an important
measure of reliability for a psychometric instrument
[39]. The purpose of this stage was to assess the temporal
accuracy of the HIVESS. An instrument is considered
relevant when a reasonable level of temporal stability can
be associated to the determined construct measures. For
assessment of test-retest reliability at least 50 participants
is required for the sample [40].
An interval of 4 weeks was considered to be an accept-
able compromise between an attempt to reduce recall
bias and test reliability independent of significant clinical
change [41]. The 17-item questionnaire was hereby ad-
ministered to participants twice over a 4-week period.
Intraclass correlation coefficients (ICCs) and the 95 %
confidence interval of the ICCs (ICC 95 % CI), as well as
paired/dependent sample t-tests were conducted as data
analyses to examine significant differences in subscale
scores from time 1 to time 2. Cronbach’s alphas were cal-
culated at both time points to examine internal consistency
of the scale.
Stage 4: convergent validity and discriminant validity
Stage 4 was intended to test the construct validity of the
HIVESS. Here we considered the extent to which infer-
ences can be made permissibly in the process of rigorously
defining variables into measurable factors. For construct
validity the theoretical constructs on which the process
was based need to be empirically and qualitatively mea-
sured. Construct validity is said to be satisfied when both
convergent and discriminant validities are satisfied [42]. A
significant correlation of 0.3 is desired between the scale
and other theoretically appropriate measures to test valid-
ity [43]. Using an alpha of 0.05 and a 1-beta equal to 0.2,
85 participants were needed to obtain a significant correl-
ation of 0.3 or more.
Based on research on exercise stereotypes in vulnerable
populations [21, 44], convergent validity of the scale was
tested by examining the relationships between the three
subscales of the HIVESS and a physical activity score [45],
exercise self-efficacy [46] and patient-reported health-
related quality of life [47]. Pearson correlation coefficients
were used to measure the association between variables.
Cronbach’s alphas were examined as internal consistency
coefficients.
As past research has reported differences between exer-
cise stereotypes in healthy individuals and people with
chronic diseases [22] or older adults [19], we examined
discriminant validity by evaluating mean differences on
the HIVESS for PLHIV and healthy individuals. Specific-
ally, significant differences were tested using univariate
analyses of covariance (ANCOVAs) while controlling for
level of exercise, age and gender. Based on the ANCOVA
result, the two groups were expected to differ in terms of
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HIV exercise stereotypes. To assess level of exercise, all
participants completed the “Physical Activity Score” [45].
The internal consistency of the items scores was examined
using Cronbach’s alpha coefficients.
Results
Stage 1: preliminary version and content clarity
Based on previous literature and content analysis of
semi-structured interviews with PLHIV, to begin with
the ad hoc committee created a pool of 30 items, ten
items for each of the three following categories of ste-
reotypes: (i) stereotypes related to exercise benefits, (ii)
stereotypes related to risks of exercise, and (iii) stereo-
types related to lack of capacity for exercise. The com-
mittee followed the Delphi method and retained 5
items for the benefits of exercise subscale and 6 items
for the subscales related to the risks of exercise and to
lack of capacity for exercise. The examination of the 17
items from the first panel of PLHIV (N = 15; Mage =
50.25; SD = 9.96) reported some low scores for clarity
across four items (3.62 <M < 3.93). The evaluation in-
terviews brought to light comments enabling modifica-
tions to be made to two items related to risks of
exercise and two items related to lack of capacity for
exercise. Higher mean clarity scores across all items
(M = 5.01; SD = .85) were produced following evaluation
of item clarity with the second sample of PLHIV (N = 15;
Mage =50.83; SD =10.21) and discussions instigated no
further modifications to the items (see Table 1). Stage 1
provided the initial 17-item HIVESS that required psycho-
metric testing. Items were rated on a 6-point Likert scale
in order to emphasize the discrimination and reliability
and to reduce the risks of deviation linked to personal
decision-making [48].
Stage 2: factorial structure analysis
A total of 96 PLHIV (Mage = 49.95; SD = 10.61) completed
the scale. A second sample of 133 PLHIV (Mage = 50.46;
SD = 10.88) was recruited to complete a modified version
of the scale.
The first CFA results did not display a good fit [i.e.,
χ2 (116, N = 96) = 267.83; CFI = .74; TLI = .78; RMSEA
= .12 (90 % CI = .10, .14)]. Retained items should satur-
ate with a weight greater than .55 as stated by Guttman
[49]. Hereby, 3 of the 17 initial items were removed
(i.e., two items on the subscale related to exercise risks
and one item on the subscale related to lack of capacity
for exercise). Using data from the same sample, a sec-
ond CFA was conducted with the 14-item scale and
showed a better fit [i.e., χ2 (74, N = 96) = 98.99; CFI
= .94; TLI = .93; RMSEA = .06 (90 % CI = .02, .09] (see
Table 1). The model was then tested with a second
sample of 133 PLHIV and also showed a satisfactory fit
[i.e., χ2 (74, N = 133) = 126.51; CFI = .92; TLI = .91;
RMSEA = .07 (90 % CI = .05, .09)]. Cronbach’s alphas
were .81 for exercise benefits, .71 for exercise risks and
.85 for lack of capacity for exercise. Stage 2 rendered
and supported the factorial structure of a 14-item,
three-factor model of the HIVESS instrument repre-
senting HIV exercise stereotype categories related to (i)
exercise benefits, (ii) exercise risks, and (iii) lack of cap-
acity for exercise.
Stage 3: temporal stability
In this stage, 50 faculty students (Mage = 23.08; SD = 2.25)
were recruited to test the temporal stability of the tool.
This population was selected as the questionnaire is not
only destined to PLHIV as a targeted group, but also to
healthy individuals as the targeters. The t-tests results are
presented in Table 2. No significant differences were
found between time 1 and time 2 in the scores within sub-
scales. Cronbach’s alpha coefficients for all three factors at
time 1 were .71, .78, .76 for exercise benefits, exercise risks
and lack of capacity for exercise respectively. At time 2,
Cronbach’s alpha coefficients were .80 for exercise bene-
fits, .82 for exercise risks and .75 for lack of capacity for
exercise. Based on these findings, the HIVESS was stable
over a 4-week period and internal reliability was persist-
ently demonstrated.
Stage 4: convergent validity and discriminant validity
In this stage, 107 (81 men and 26 women) PLHIV (Mage =
52.51; SD = 11.42) were recruited to test convergent valid-
ity. The discriminant validity of the scale was assessed
using the same sample of PLHIV and a sample of 104
(62 men and 45 women) healthy adults (Mage = 28.04;
SD = 10.45).
Convergent validity
Correlational analyses indicated that stereotypes related
to lack of capacity for exercise and exercise risks among
PLHIV were negatively related to exercise self-efficacy
and level of physical activity. Exercise risks and lack of
capacity for exercise were negatively related to patient-
reported health-related quality of life. The exercise
benefits stereotypes subscale was positively related to
self-efficacy and level of physical activity (see Table 3).
Quality of life did not reveal a significant relation to the
exercise benefits subscale. Cronbach’s alphas were .77,
.69 and .76 for exercise benefits, risks and lack of
capacity for exercise respectively.
Discriminant validity
ANCOVA analyses including control for level of exercise
(see Table 4) revealed significant differences between
PLHIV and healthy individuals for subscales related to the
HIVESS. Cronbach’s alphas were all satisfactory (.77 for
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exercise benefits; .69 for exercise risks; and .77 for lack of
capacity for exercise) in PLVIH and in healthy individuals
(.71 for exercise benefits; .80 for exercise risks; and .80 for
lack of capacity for exercise).
Assessments for convergent and discriminant validity,
founded on the construct validity, displayed the HIVESS
as being significantly related to exercise, exercise self-
efficacy and quality of life in the anticipated directions.
Table 1 Items and Clarity Scores for the Preliminary Version of the HIVESS
Dimensions Items Clarity
Scores (M)
Stereotypes related to benefits
of exercise
1. La pratique d’une activité physique permet d’améliorer le moral des patients atteints de VIHb
Exercise improves the morale of HIV-infected patients
5.6
2. La pratique d’une activité physique réduit les effets de la maladie chez les patients atteints de VIHb
Exercise reduces the effects of the disease in
HIV-infected patients
4.8
3. La pratique d’une activité physique améliore le bien-être des patients atteints de VIHb
Exercise enhances well-being in HIV-infected patients
5.6
4. La pratique d’une activité physique permet aux patients atteints de VIH de se sentir mieux
physiquementb
Exercise allows HIV-infected patients to feel better physically
5.3
5. La pratique d’une activité physique améliore la survie chez les patients atteints de VIHb
Exercise betters the chances of survival in HIV-infected patients
4.1
Stereotypes related to risks
of exercise
1. Les patients atteints de VIH ne font pas d’activité physique car ils peuvent contaminer quelqu’un au
cours de la pratiqueb
HIV-infected patients do not exercise because they can contaminate someone during the activity
4.2
2. La pratique d’une activité physique doit être évitée par les patients atteints de VIH car elle provoque
des blessuresb
Exercising should be avoided by HIV-infected patients because it causes injuries
4.1
3. Les patients atteints de VIH ne font pas d'activité physique car ils redoutent de contaminer
quelqu'un au cours de la pratiqueb
HIV-infected patients do not exercise because they fear contaminating someone during this activity
4.8
4. La pratique d’une activité physique est dangereuse pour les patients atteints de VIH car elle entraîne
trop d’essoufflementsa
Exercising should be avoided by HIV-infected patients because it causes too much breathlessness
5.1
5. Les patients atteints de VIH ne font pas d’activité physique car ils peuvent contaminer quelqu’un
suite à une blessureb
HIV-infected patients do not exercise because they could contaminate someone after getting injured
4.9
6. La pratique d’une activité physique entraîne trop de fatigue chez les patients atteints de VIHa
Exercising causes too much fatigue for HIV-infected patients
5.5
Stereotypes related to lack
of capacity for exercise
1. Les patients atteints de VIH n’ont pas les ressources physiques suffisantes pour faire de l’activité
physiqueb
HIV-infected patients do not have enough physical resources to exercise
5.1
2. Les patients atteints de VIH ont des capacités physiques trop limitées pour faire de l'activité
physique à cause des traitementsa
HIV-infected patients’ physical capacities are too limited to exercise due to their treatments
5.2
3. Les patients atteints de VIH ne sont pas capables physiquement de faire de l'activité physiqueb
HIV-infected patients are not physically apt to exercise
4.9
4. A cause des traitements, les patients atteints de VIH n’ont plus assez d’énergie pour faire de l'activité
physiqueb
Because of treatments, HIV-infected patients do not have enough energy to exercise
5.3
5. Les douleurs musculaires et articulaires causées par les traitements empêchent les patients atteints
de VIH de faire de l'activité physiqueb
Muscle and joint pain caused by the treatments prevent HIV-infected patients from exercising
5.2
6. Les patients atteints de VIH ne font pas d’activité physique car ils sont trop fatigués par les
traitementsb
HIV-infected patients do not exercise because they are too tired due to their treatments
5.6
Notes: English translations are in italics. For each item, the participant had to answer on a 6-point Likert-type scale from 1 (do not agree at all) to 6 (totally agree).
M =Mean clarity scores
aDeleted items following the first CFA
bRetained items in the final model
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In addition the expected differences between PLHIV and
healthy individuals were evidenced as regards to negative
stereotypes related to exercise risks and lack of capacity
for exercise.
Discussion
Although several scales have been developed to measure
psychological constructs in people living with HIV [50],
the HIV Exercise Stereotype Scale is the first scale to
record exercise stereotypes in this population. This scale
was developed based both on literature related to psy-
chological barriers to exercise among PLHIV [51, 52]
and existing scales measuring exercise stereotypes in the
elderly [19] and cancer patients [22]. The scale consists
of 14 items divided into three subscales: (a) stereotypes
related to exercise benefits, (b) stereotypes related to ex-
ercise risks and, (c) stereotypes related to lack of cap-
acity for exercise. The instrument tested in this study
demonstrated good structure, strong reliability and indi-
cators of validity.
Stereotypes related to benefits of exercise were assessed
by items focused on the positive effects of exercise (e.g.,
“Physical activity improves the morale of HIV-infected
patients”). This subscale was the most highly endorsed
by the HIVESS. However, we do not observe a signifi-
cant positive effect of exercise benefits on exercise self-
efficacy and self-reported level of physical activity. This
discordance encourages questioning the gap between
acknowledging the benefits of exercise and actually be-
ing physically active [52]. Nonetheless, this gap is not
specific to PLHIV but is noted in the general popula-
tion [51]. Some studies link the coexistence of positive
views of exercise and the lack of exercise among PLHIV
to: lack of motivation or lack of time [14, 15], but also
to population-specific barriers such as fear of worsen-
ing the illness [12], which seems to reflect exercise risks
stereotypes.
The items describing stereotypes related to the risks of
exercise for PLHIV conveys the idea that exercise in-
creases the risk of injury (e.g., “Practicing a physical activ-
ity should be avoided by HIV-infected patients because it
causes injuries”) and the risk of contamination (e.g., “HIV-
infected patients do not practice physical activities be-
cause they could contaminate someone during the activ-
ity”). PLHIV showed the least agreement to this subscale,
whereas healthy individuals revealed higher scores for
exercise risk stereotypes for PLHIV. Furthermore, exercise
risks were negatively related to exercise self-efficacy, self-
reported level of physical activity and patient-reported
health-related quality of life. This suggests that, although
PLHIV present barriers to exercise linked to exercise risk
such as fear of sustaining an injury during exercise [15],
there is a certain resistance to exercise risk stereotype
embodiment [17] by PLHIV as already evidenced in older
adults [19].
Items describing stereotypes related to lack of capacity
for exercise included items pertaining to exercise self-
efficacy in PLHIV, treatment side effects, as well as per-
ceptions of physical fatigue (e.g., “HIV-infected patients
do not have enough physical resources to practice a
physical activity”). This type of stereotype is consistent
with existing exercise barriers previously reported in the
literature in terms of low levels of exercise capacity and
energy [14, 15]. Stereotypes linked to lack of capacity for
exercise were negatively related to exercise self-efficacy,
self-reported level of physical activity and health-related
quality of life. Here again, we note that healthy individuals
had a slightly higher level of endorsement than PLHIV.
The moderate-level agreement of this type of stereotype is
consistent with findings among cancer patients [22] and
older adults [19], whereby a stereotype pertaining to loss
of physical capabilities was also reported. These findings
provide support to the assumption that individuals are
more likely to develop negative stereotypes when the latter
have no strong self-referential implications [52].
The scale indicated good internal consistency and stable
test-retest reliability. The correlations and regression ana-
lyses confirm convergent validity of the HIVESS with a
measure of exercise self-efficacy, the level of physical ac-
tivity and patient-reported health-related quality of life.
The negative HIV exercise stereotypes related to the risks
of exercise and to the lack of capacity for exercise were
inversely related to exercise self-efficacy, level of physical
activity and health-related quality of life. No significant
Table 2 Descriptive Statistics for the Questionnaire Structure in
Stage 3
Time 1 (N = 50) Time 2 (N = 50)
M (SD) α M (SD) α t-tests
LCE 3.05 (.81) .77 3.18 (.78) .75 t(98) = -.83, p = .41
RE 2.50 (1.09) .78 2.42 (1.12) .82 t(98) = .34, p = .73
BE 4.45 (.85) .71 4.50 (.79) .80 t(98) = -.26, p = .80
Notes: LCE Stereotypes related to lack of capacity for exercise, RE Stereotypes
related to risks of exercise, BE Stereotypes related to benefits of exercise, M
Mean, SD Standard Deviation; t-tests: Student’s t-test; α: Cronbach’s alpha
Table 3 Matrix of Pearson’s r Correlations in Stage 4 (N = 109)
BE RE LCE SE PAS QoL
BE -
RE -.15* -
LCE .07 .32 -
SE .28 -.32* -.48* -
PAS .21 -.11* -.18* .41** -
QoL .14 -.32** -.45** -.32** -.03 -
Notes: BE: Stereotypes related to benefits of exercise; RE: Stereotypes related
to risks of exercise; LCE: Stereotypes related to lack of capacity for exercise; SE:
Self-efficacy; PAS: Physical activity score; QoL: Quality of life; *p < .05; **p < .001
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results were observed for positive HIV exercise stereo-
types evaluating the benefits of exercise warranting further
investigation. Divergent validity was supported by signifi-
cant differences noted between healthy individuals and
PLHIV for subscales related to lack of capacity for exercise
and exercise risks with healthy individuals scoring higher
for both these subscales.
Conclusion
The HIVESS is a reliable and valid tool to measure HIV
exercise stereotypes in PLHIV. However, it is important
to point out some limitations of the scale. The proced-
ure reported in this paper is limited by the sociodemo-
graphic characteristics of the samples. For example, our
data includes a majority of men and it would be inter-
esting to have a more balanced gender distribution.
Moreover, test-retest reliability was run in a sample of
faculty students and not PLHIV. This could possibly
lead to some limits in the generalizability of the scale.
In addition, the HIVESS, which was first developed in
French, would need to be translated in other languages
in order to be used internationally.
The HIVESS allows for further investigation on psy-
chological barriers to exercise in PLHIV. A first line of
further research could try to identify the relationship
between HIV exercise stereotypes and level of exercise.
A second line of research could examine the modera-
tors of HIV exercise stereotypes endorsement (such as
being physically active vs. inactive and being healthy vs.
HIV-positive). A third line of research could focus on
the consequences of exercise stereotypes embodiment
on levels of exercise and the potential role of fatigue
which has been identified as prevalent complaint among
PLHIV [50, 53] affecting quality of life. The French-
language HIVESS is a concise multi-item scale facilitating
completion and enabling extensive use both in clinical
and research environments.
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